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colorectal cancers of Vietnamese and Japanese
patients
Tomohiro Miwata1, Toru Hiyama2*, Duc Trong Quach3, Huy Minh Le4, Ha Ngoc Thi Hua4, Shiro Oka5,
Shinji Tanaka5, Koji Arihiro6 and Kazuaki Chayama1Abstract
Background: The incidence of early-onset (under 50 years of age) colorectal cancer (CRC) in the Vietnamese has
been reported to be quite higher than that in the Japanese. To clarify the differences in genetic alterations between
Vietnamese and Japanese CRCs, we investigated mutations in K-ras and mitochondrial DNA (mtDNA) and high-frequency
microsatellite instability (MSI-H) in the CRCs of Vietnamese and Japanese patients.
Methods: We enrolled 60 Vietnamese and 233 Japanese patients with invasive CRCs. DNA was extracted from
formalin-fixed, paraffin-embedded tissue sections. K-ras mutations were examined with PCR-single-strand conformation
polymorphism analysis. mtDNA mutations and MSI-H were examined with microsatellite analysis using D310 and BAT-26,
respectively.
Results: K-ras mutations were examined in 60 Vietnamese and 45 Japanese CRCs. The frequency of the mutations in the
Vietnamese CRCs was significantly higher than that in the Japanese CRCs (8 of 24 [33%] vs 5 of 45 [11%], p =0.048). MSI-H
was examined in 60 Vietnamese and 130 Japanese CRCs. The frequency of MSI-H in the Vietnamese CRCs was also
significantly higher than that in the Japanese CRCs (6 of 27 [22%] vs 10 of 130 [8%], p =0.030). mtDNA mutations were
examined in 60 Vietnamese and 138 Japanese CRCs. The frequency of mtDNA mutations in the Vietnamese CRCs was
significantly higher than that in the Japanese CRCs (19 of 44 [43%] vs 11 of 133 [9%], p <0.001). There were no significant
differences in clinicopathologic characteristics, such as age, sex, tumour location, and depth, in terms of tumours
with/without each genetic alteration in the CRCs of the Vietnamese and Japanese patients.
Conclusions: These results indicate that the developmental pathways of CRCs in the Vietnamese may differ from those
of CRCs in the Japanese.
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Colorectal cancer (CRC) is one of the most common
cancers in the world. Especially, the incidences and
mortality rates of CRCs in developing and economically
transitioning countries are rapidly rising [1]. Vietnam is
one of the developing countries in Asia, and Japan is one
of the developed countries. In Vietnam, CRC is the
third most common cause of cancer deaths in men
and fourth in women [2]. In addition, a high inci-
dence of early-onset CRC (that occurring in patients
under 50 years of age) has been reported: the ratio of
early-onset CRC to all CRCs is approximately 28%
[2]. On the other hand, CRC is the third most common
cause of cancer death in men and first in women in
Japan. The ratio of early-onset CRC to all CRCs is
reported to be approximately 6% [3]. Thus, the incidence
of early-onset CRCs in the Vietnamese may be quite
higher than that in the Japanese, implying that the
pathways of CRC development, i.e. the pattern of genetic
changes in CRCs, in the Vietnamese may differ from those
in the Japanese.
To date, at least 3 distinct pathways of CRC development
are known [4-6]. One is the chromosomal instability
pathway, which is present in 65–70% of CRCs. It is
associated with the activation of oncogenes, such as
K-ras mutations, and the inactivation of tumour sup-
pressor genes such p53 and DCC. Second is the
microsatellite instability (MSI) pathway, which is
present in approximately 15% of CRCs. Third is the
mitochondrial DNA (mtDNA) dysfunction pathway,
which is present in approximately 5% of CRCs. However,
there are few studies on the genetic alterations in
CRCs in the Vietnamese. Therefore, we investigated
mutations of K-ras and mtDNA and high-frequency
MSI (MSI-H), the representative genetic alterations of
the 3 pathways, in the CRCs of Vietnamese and Japanese
patients to clarify the differences between CRCs in these
two populations.
Methods
Patients
We enrolled 60 patients with invasive CRCs diagnosed
at the Department of Endoscopy, University Medical
Center in Ho Chi Minh, Vietnam, between March 2009
and March 2011, and 233 patients with invasive CRCs
diagnosed at the Department of Endoscopy, Hiroshima
University Hospital, Hiroshima, Japan, between 1998 and
2010. The patients’ clinicopathologic data were retrieved
from the databases of both hospitals. This retrospective
study was approved by the ethical committees of both
the University Medical Center in Ho Chi Minh and
Hiroshima University. Written informed consent was
obtained from the patient for the publication of this
report and any accompanying images.DNA extraction and amplification
Formalin-fixed, paraffin-embedded tissue sections of 10 μm
in thickness were stained with haematoxylin and eosin,
dehydrated in graded ethanol, and then dried without a
cover glass. Tissues were cut with sterile scissors, and the
DNA was extracted from the tissues with 20 μl of extraction
buffer (100 mM Tris–HCl; 2 mM ethylene diamine tetraa-
cetic acid, pH 8.0; and 400 μg/ml proteinase K) at 55°C for
3 h. The tubes were boiled for 7 min to inactivate protein-
ase K, and then 1–5 μl of these extracts was used for each
polymerase chain reaction (PCR) amplification [7].
Mutational screening and direct sequencing of K-ras
DNA samples were screened for mutations of K-ras by
PCR-single-strand conformation polymorphism (SSCP)
analysis. The PCR primers were designed to amplify
mutation hot spots, codons 12 and 13, of the K-ras
[8]. PCR-SSCP analysis was performed as described
previously [8]. Briefly, each 25-μL reaction mixture
contained 1 × AmpliTaq Gold Buffer (8.0 mmol/L
Tris–HCl, pH 8.3; 40 mmol/L KCl; Perkin-Elmer,
Branchburg, NJ, USA), 4 mmol/L MgCl2, 0.3 mmol/L
of each deoxynucleotide triphosphate, 100 pmol of
each primer, 10–20 ng genomic DNA, 2.5 mCi [α
32-P]
dCTP (3000 Ci/mmol/L, 10 mCi/mL), and 1.25 U
AmpliTaq Gold DNA polymerase (Perkin-Elmer). The
reaction mixtures were heated to 95°C for 10 min,
followed by 45 cycles of denaturation at 94°C for 1 min,
annealing at 55°C for 2 min, and strand elongation at 72°C
for 2 min. After PCR, the samples were electrophoresed
on 6% polyacrylamide gels (ratio of acrylamide:bis-
acrylamide, 19:1) with 10% glycerol at 4°C. The gels were
then subjected to autoradiography overnight at −80°C on
Fuji RX film (Fuji Film, Minamiashigara, Japan).
Microsatellite assay
A microsatellite marker, BAT-26, was used to examine
MSI-H [9]. The microsatellite assay was performed as
described previously [10]. Briefly, each 15-μL reaction
mixture containing 10–20 ng of genomic DNA, 6.7 mmol
Tris–HCl (pH 8.8), 6.7 mmol EDTA, 6.7 mmol MgCl2,
0.33 μmol primer labelled with (gamma-32P) dATP,
0.175 μmol unlabelled primer, 1.5 mmol of each deoxynu-
cleotide triphosphate, and 0.75 units of AmpliTaq Gold
DNA polymerase was amplified for 40 cycles as follows:
denaturation at 94°C for 30 s, annealing at 55°C for 30 s,
and strand elongation at 72°C for 30 s. The PCR products
were electrophoresed on 6% polyacrylamide, 8 mol urea,
and 32% formamide gels and subjected to autoradiography
overnight at −80°C on Fuji RX film.
Mutational analysis of mtDNA
A 109-bp fragment containing the D310 repeat of mtDNA,
the D-loop region, was amplified. The primer sequences
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for the sense primer and 5’-GGCAGAGATGTGTT
TAAGTGCTG-3’ for the antisense primer [5]. The micro-
satellite assays were carried out to analyse the mutation of
the D310 repeat of mtDNA.
Statistical analysis
We compared the frequency of genetic abnormalities
between the CRCs of the Vietnamese and Japanese
patients. Statistical differences were evaluated using
the Student t-test, χ2 test, and Fisher’s exact probability
test. A value of p <0.05 was regarded as statistically
significant.
Results
The clinicopathologic characteristics of informative cases
of K-ras, mtDNA, and MSI analyses are shown in Tables 1,
2, and 3, respectively. A summary of genetic alterations is
shown in Table 4.
K-ras mutations were examined in the CRCs of 60
Vietnamese and 45 Japanese patients (Figure 1A). Of
these CRCs, 24 from the Vietnamese and all 45 from the
Japanese patients were informative in the analysis. The
clinicopathologic characteristics of the informative cases
are shown in Table 1. The details of the Japanese data
have been reported previously [4]. The frequency of the
mutations in the Vietnamese CRCs was significantly
higher than that in the Japanese CRCs (8 of 24 [33%] vs
5 of 45 [11%], p =0.048) (Table 4). There were no significant
differences in the clinicopathologic characteristics, such as
age, sex, tumour location, and depth, of the Vietnamese
and Japanese patients in terms of tumours with or without
K-rasmutations (data not shown).
MSI-H was examined in the CRCs of 60 Vietnamese
and 130 Japanese patients (Figure 1B). Of these CRCs,
27 in the Vietnamese and all 130 in the Japanese patients
were informative in the analysis. The clinicopathologic
characteristics of the informative cases are shown in
Table 2. The frequency of MSI-H in the Vietnamese CRCsTable 1 Clinicopathologic features of informative cases of
Vietnamese and Japanese CRCs undergoing K-ras analysis
Vietnamese CRC
(n = 24)
Japanese CRC
(n = 45)
p-value
Age, mean (range) 53.0 (32–79) 62.9 (42–87) 0.006
Sex, male/female 15/9 31/14 0.60
Tumour location
Right/left side* 6/18 16/29 0.43
Histology
Well/moderately/poorly
differentiated
0/20/4 36/9/0 0.012
*Right-side colon includes the cecum, ascending and transverse colon.
Left-side colon includes the descending and sigmoid colon and rectum.
CRC, colorectal cancer.was significantly higher than that in the Japanese CRCs
(6 of 27 [22%] vs 10 of 130 [8%], p =0.030). There
were no significant differences in the clinicopathologic
characteristics of the Vietnamese and Japanese patients
in terms of tumours with or without MSI-H (data not
shown).
mtDNA mutations were examined the CRCs of 60
Vietnamese and 138 Japanese patients (Figure 1C).
Of these CRCs, 44 in the Vietnamese and 133 in the
Japanese were informative in the analysis. The clinicopath-
ologic characteristics of the informative cases are shown
in Table 3. The details of the Japanese data have also been
reported previously [5]. The frequency of the mutations in
the CRCs in the Vietnamese was significantly higher than
that in the CRCs of the Japanese (19 of 44 [43%] vs 11 of
133 [9%], p <0.001). There were no significant differences
in the clinicopathologic characteristics of the Vietnamese
and Japanese patients in terms of tumours with or without
mtDNA mutations (data not shown).
Discussion
We demonstrated that the frequencies of mutations of
K-ras and mtDNA and the frequency of MSI-H were
significantly higher in the CRCs of the Vietnamese than
in those of the Japanese patients. These results indicate that
the developmental pathways of CRCs in the Vietnamese
may differ from those of CRCs in the Japanese. This is, to
our knowledge, truly the first report of genetic alterations
in K-ras and mtDNA and of MSI-H in CRCs of Vietnamese
patients.
Carcinogenesis and the progression of CRC are multistep
processes involving the accumulation of genetic alterations.
Much attention has been directed to the study of genetic
events such as the activation of oncogenes, inactivation
of tumour suppressor genes due to mutations and methyl-
ations, defects in mismatch repair genes, and mutations of
mtDNA.
K-ras, one of the major oncogenes, encodes the 21-kD
plasma membrane-bound guanosine triphosphate-binding
protein, which is a key regulatory component of signal
transduction pathways that transmit growth stimulatory
signals from cell surface receptors to intracellular targets
[8]. The majority of the mutations involve a single amino
acid submission at codon 12 or 13, which decreases the
intrinsic guanosine triphosphatase activity and which leads
to the constitutive activation of the K-ras signaling
pathway. K-ras mutations are found in 20–30% of
CRCs in the Japanese [11,12]. The frequency of K-ras
mutations in the CRCs of the Japanese in the present
study was lower than that in previous reports. This
may be due to differences of sensitivity in the assay
used and to differences in the examined locus. Even so,
K-ras mutations were found significantly more frequently
in the CRCs of the Vietnamese than Japanese patients.
Table 2 Clinicopathologic features of informative cases of
Vietnamese and Japanese CRCs undergoing microsatellite
instability analysis
Vietnamese CRC
(n = 27)
Japanese CRC
(n = 130)
p-value
Age, mean (range) 50.0 (34–80) 63.2 (32–86) <0.001
Sex, male/female 18/9 78/52 0.67
Tumour location
Right/left side* 6/21 35/95 0.79
Histology
Well/moderately/poorly
differentiated
1/23/3 76/54/0 0.005
*Right-side colon includes the cecum, ascending and transverse colon.
Left-side colon includes the descending and sigmoid colon and rectum.
CRC, colorectal cancer.
Table 4 Summary of genetic alterations in Vietnamese
and Japanese CRCs
Genetic alteration Vietnamese
CRCs
Japanese
CRCs
p-value
K-ras mutation, present 8/24 (33%) 5/45 (11%) 0.048
MSI-H, present 6/27 (22%) 10/130 (8%) 0.030
mtDNA mutation, present 19/44 (43%) 11/133 (8%) <0.001
CRCs, colorectal cancers; MSI-H, high-frequency microsatellite instability;
mtDNA, mitochondrial DNA.
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between the CRCs in the Vietnamese and Japanese.
Moderately differentiated CRC was predominant (83%
of the informative cases) in the Vietnamese, whereas
well-differentiated CRC was predominant in the Japanese
patients (80% of the informative cases). Although some
researchers may think that a difference in histology might
be associated with the difference in the frequency of K-ras
mutations, to date, many reports show no associations
between K-ras mutations and histologic grades [13-15],
and therefore, other factors may be associated with the
higher frequency of K-ras mutations in the Vietnamese
CRCs. It is well known that K-ras mutations are associated
with polypoid-type colorectal tumours but not with
flat-type tumours [16]. The data on macroscopic subtypes
in the CRCs examined in the present study were insuffi-
cient because most of the CRCs were at advanced stages;
thus, it was unclear whether they were of polypoid- or
flat-type origin. The association of K-ras mutations and
macroscopic views in the Vietnamese CRCs should be
examined in the early stages of tumours. If the polypoid
type, which contains a high frequency of K-ras mutations,Table 3 Clinicopathologic features of informative cases of
Vietnamese and Japanese CRCs undergoing mitochondrial
DNA analysis
Vietnamese CRC
(n = 44)
Japanese CRC
(n = 133)
p-value
Age, mean (range) 54.0 (32–82) 63.7 (37–88) <0.001
Sex (male, female) 29/15 82/51 0.61
Tumour location
Right/left side* 10/34 32/101 0.98
Histology
Well/moderately/poorly
differentiated
1/37/6 41/82/10 0.22
*Right-side colon includes the cecum, ascending and transverse colon.
Left-side colon includes the descending and sigmoid colon and rectum.
CRC, colorectal cancer.is predominant in these CRCs, this may be another
characteristic unique to Vietnamese CRCs.
Recently, mutations of mtDNA have been reported in
various types of human cancers [5,17], as have frequent
mutations of the D-loop region of mtDNA [18-20]. The
D-loop is the region that is critical for replication and
expression of the mitochondrial genome because it
contains the leading-strand origin of replication and
the major promoters for transcription. Habano et al.
[21] reported that 44% of Japanese CRCs have mutations
of the D-loop region. The frequency of mtDNA mutations
in the Japanese CRCs in the present study was lower than
that reported by Habano et al. This may be due to differ-
ences in the sensitivity of the assay used and to differences
in the examined locus. Regardless, the frequency of theFigure 1 Representative examples of genetic analyses. The
patient ID number is indicated above each lane. (A) K-ras mutation
by PCR-SSCP analysis. Patient V5 shows mobility shift, indicating the
mutation (*). (B) High-frequency microsatellite instability (MSI-H) by
microsatellite assay. Patient J3 shows additional bands, indicating
the MSI-H (*). (C) Mitochondrial DNA mutation by microsatellite
assay. Patient V23 shows mobility shift, indicating the mutation (*).
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higher than that in the CRCs of the Japanese patients.
mtDNA mutations are also reported to have no asso-
ciation with histologic differences or K-ras mutations
in many studies [20].
MSI-H is caused by the inactivation of DNA mis-
match repair genes such as hMSH2 and hMLH1 [6].
Approximately 90% of CRCs in patients with hereditary
non-polyposis CRC (HNPCC) show MSI-H. MSI-H CRCs
have been reported to be more frequently associated with
early onset, proximal tumour location, poorly differenti-
ated and mucin-containing histology, low lymph node
metastasis, and better survival rate [20]. MSI-H has been
detected in 6–14% of Japanese CRCs [22,23], and our
result was similar to that in these previous reports. In the
present study, the frequency of MSI-H was significantly
higher in the Vietnamese CRCs than in the Japanese
CRCs. It is hypothesised that HNPCC may occur more
frequently in the Vietnamese than in the Japanese. The
incidence of early-onset CRC in Vietnamese has been
reported to be high [2]. The finding that a higher
frequency of poorly differentiated histology was observed
in the Vietnamese CRCs than in the Japanese CRCs
in the present study is compatible with this hypothesis.
Further studies to clarify the frequency of HNPCC in the
Vietnamese population are needed.
Why is the incidence of early-onset CRC in the
Vietnamese greater than that in the Japanese, and
why do Vietnamese CRCs contain higher frequencies
of genetic alterations, especially those of K-ras and
mtDNA mutations? One possible reason might be the
differences in ethnicity between the two populations.
A second possible reason might be the differences in
cultural habits including diet and lifestyle between the
two peoples. Although both countries are in Asia, Vietnam
is a developing country, and Japan is a developed country.
Common diseases differ between the countries: infectious
diseases are prevalent in Vietnam, whereas lifestyle-related
diseases dominate in Japan. Differences in environmental
factors may also be associated with the differences in
the genetic background of the CRCs. A third possible
reason might be found in the history of Vietnam. During
the Vietnamese war, American military forces spread great
amounts of the herbicide Agent Orange in Vietnam. The
agent was a mixture of 2,4-dichlorophenoxyacetic acid
(2,4-D) and 2,4,5-trichlorophenoxyacetic acid (2,4,5-T),
which was contaminated with dioxin, a toxic chemical
shown to have carcinogenic effects [24]. Among US
military veterans who were in the Vietnamese war, the risk
of cancer at any site including CRC is increased [25].
There are several limitations in the present study. First
is the relatively small number of patients included, for
which sampling bias might exist. All of the Vietnamese
samples were obtained in a university medical centre inHo Chi Minh, and it is possible that the patients were
not a good representation of the whole Vietnamese
population. Likewise, all of the Japanese samples were
obtained in a university hospital in Hiroshima, and these
patients also may not be representative of the whole
Japanese population. Second is the number of genes
examined; we examined only K-ras, mtDNA, and
MSI-H. A more detailed view is needed. Third is the
presence of a possible bias in the sampling period of
the two groups. Differences in diagnosis might exist
between the relatively small sampling period of 2 years
in the Vietnamese and 12 years in the Japanese. In
addition, an increase in the frequency of K-ras mutations
in CRCs in the 1990s compared with that in the 1960s has
been reported [26]. This implies that the frequency of
genetic alterations may differ during different time periods.
Conclusions
We demonstrated that CRCs in the Vietnamese patients
may involve significantly more frequent changes in K-ras
and mtDNA genes and in microsatellite regions compared
with CRCs in the Japanese patients, indicating that
the developmental pathways of CRCs in the Vietnamese
may differ from those in the Japanese. Further studies with
a larger number of patients and more target genes are
needed to clarify the differences between CRCs in the
Vietnamese and Japanese populations.
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